DE69418931T2 - Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten - Google Patents

Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten

Info

Publication number
DE69418931T2
DE69418931T2 DE69418931T DE69418931T DE69418931T2 DE 69418931 T2 DE69418931 T2 DE 69418931T2 DE 69418931 T DE69418931 T DE 69418931T DE 69418931 T DE69418931 T DE 69418931T DE 69418931 T2 DE69418931 T2 DE 69418931T2
Authority
DE
Germany
Prior art keywords
vip
peptide
use according
radical
lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69418931T
Other languages
German (de)
English (en)
Other versions
DE69418931D1 (de
Inventor
Matityahu Fridkin
Illana Gozes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd, Yeda Research and Development Co Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of DE69418931D1 publication Critical patent/DE69418931D1/de
Application granted granted Critical
Publication of DE69418931T2 publication Critical patent/DE69418931T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69418931T 1993-03-16 1994-03-08 Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten Expired - Fee Related DE69418931T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Publications (2)

Publication Number Publication Date
DE69418931D1 DE69418931D1 (de) 1999-07-15
DE69418931T2 true DE69418931T2 (de) 2000-03-16

Family

ID=11064619

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418931T Expired - Fee Related DE69418931T2 (de) 1993-03-16 1994-03-08 Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten

Country Status (7)

Country Link
EP (1) EP0620008B1 (OSRAM)
JP (1) JPH0769919A (OSRAM)
KR (1) KR100305453B1 (OSRAM)
CN (1) CN1140294C (OSRAM)
DE (1) DE69418931T2 (OSRAM)
IL (1) IL105061A (OSRAM)
TW (1) TW290458B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
US6713445B1 (en) * 1998-04-06 2004-03-30 Advanced Immuni T, Inc. Peptides for treatment of HIV infection
CA2420550A1 (en) * 2000-08-24 2002-02-28 Thomas Jefferson University Peptide with effects on cerebral health
WO2002043746A2 (en) 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
ATE425763T1 (de) 2002-06-10 2009-04-15 Mondobiotech Licensing Out Ag Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
WO2008054498A2 (en) * 2006-04-07 2008-05-08 The Board Of Trustees Of The University Of Illinois Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders
KR101242066B1 (ko) 2010-05-19 2013-03-12 강원대학교산학협력단 Ｖｉｐ를 유효성분으로 함유하는 기분장애 예방 및 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9166291A (en) * 1990-12-21 1992-07-22 Case Western Reserve University Neuronal cholinergic differentiation factor
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL105061A (en) 2000-11-21
CN1100327A (zh) 1995-03-22
EP0620008A1 (en) 1994-10-19
TW290458B (OSRAM) 1996-11-11
IL105061A0 (en) 1993-07-08
KR100305453B1 (ko) 2001-11-22
KR940021074A (ko) 1994-10-17
CN1140294C (zh) 2004-03-03
DE69418931D1 (de) 1999-07-15
EP0620008B1 (en) 1999-06-09
JPH0769919A (ja) 1995-03-14

Similar Documents

Publication Publication Date Title
DE69016691T2 (de) Lineare Somatostatin-Analoga.
DE69722397T2 (de) Insulin-derivate und ihre verwendung
DE69433090T2 (de) Conotoxine, die an den acetylcholinrezeptor anbinden
DE60012721T2 (de) Analoge des magensaft inhibierenden peptides und ihre verwendung für die behandlung von diabetes
EP0763061B1 (de) Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
DE69110101T2 (de) GIP-Analoge und deren Verwendung.
DE68929217T2 (de) Insulinotropes hormon
EP0132770B1 (de) Neue Insulin-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie pharmazeutische Mittel zur Behandlung des Diabetes mellitus
DE69913242T2 (de) Peptidanaloge des Glucagon-ähnlichen-Peptids-1 (7-37), deren Herstellung und pharmazeutische Zusammensetzungen
DE69736712T2 (de) Verfahren zur milderung von neuropatischen schmerz mit prosaposin verwandten peptiden
DE69525177T2 (de) Neurotrophe peptide des aktivitätsabhängigen neurotrophen faktors
DE3851002T2 (de) Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.
DE2431776A1 (de) Neue peptidzusammensetzungen
DE69737065T2 (de) Insulin c-peptide
US5972883A (en) Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE2921216C2 (OSRAM)
DE60214135T2 (de) Modifizierte derivate von cck-8
DE69007739T2 (de) Polypeptide verwertbar als Kalziumkanälen-Blocker.
CH679045A5 (OSRAM)
CH676425A5 (OSRAM)
DE3881467T2 (de) Vasokonstriktor-Peptid.
DE69028692T2 (de) Substance P Antagoniste
DE69025763T2 (de) Vasodilatierende und immunsupprimierende peptide
DE69312320T2 (de) Den kalzium kanal blokierende polypeptide aus filistata hibernalis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee